Stakeholders
Topics
Institute for Value-Based Medicine
About AJMC
CME/CE
Subscribe
- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Paranagama D, Colucci P, Evans KA, Bonafede M, Parasuraman S. Are patients with high-risk polycythemia vera receiving cytoreductive medications? a retrospective analysis of real-world data. Exp Hematol Oncol. 2018, 7:16. doi: 10.1186/s40164-018-0107-8.
home / authors / paranagama-d-colucci-p-evans-ka-bonafede-m-parasuraman-s-are-patients-with-high-risk-polycythemia-vera-receiving-cytoreductive-medications-a-retrospective-analysis-of-real-world-data-exp-hematol-oncol-2018
